Premium
Potential cancer risk with omalizumab? A disproportionality analysis of the WHO's VigiBase pharmacovigilance database
Author(s) -
Mota Diogo,
Rama Tiago Azenha,
Severo Milton,
Moreira André
Publication year - 2021
Publication title -
allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.363
H-Index - 173
eISSN - 1398-9995
pISSN - 0105-4538
DOI - 10.1111/all.15008
Subject(s) - medicine , pharmacovigilance , humanities , philosophy , pharmacology , adverse effect